Who currently markets Predonine (prednisolone) and who is the marketing authorisation holder in 2025?
I can’t answer this accurately from the information provided. “Predonine” is a brand name for prednisolone, but the marketing owner/marketing authorisation holder can vary by country and by specific product strength/formulation.
To identify the 2025 marketing owner correctly, you need at least:
- the country (e.g., UK, Germany, India, Australia, etc.), and
- the exact product (tablet vs. syrup/solution, and strength).
If you share the country (or a photo/text of the label/box front), I can help you pinpoint the marketing authorisation holder from the product information you provide.
Does “Predonine” have different owners depending on the country?
Yes. For the same active ingredient (prednisolone), different companies can hold the marketing authorisation for “Predonine” in different markets, and sometimes even for different dosage forms.
Is “marketing owner” the same as “manufacturer” or “MAH”?
Not necessarily.
- The “marketing owner” often means the company responsible for marketing and regulatory status in that country.
- The “manufacturer” is the site/company that makes the product.
- The “MAH” (marketing authorisation holder) is the legal entity that holds the approval.
These can be different entities.
What to look for on the box to confirm the 2025 marketing owner
Check the packaging for wording like:
- “Marketing authorisation holder (MAH)”
- “Held by”
- “Distributed by”
- “Manufactured by”
- “Authorisation No.” / “PL/MA number” (country-specific)
How can you get a precise answer fast?
Reply with:
1) your country, and
2) the dosage form and strength shown on your “Predonine” pack (e.g., tablets 5 mg, syrup, etc.).
Then I’ll help you identify the marketing authorisation holder/marketing owner for that exact product in 2025.